BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 9058378)

  • 21. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements.
    Bruzdzinski CJ; Johnson MR; Goble CA; Winograd SS; Gelehrter TD
    Mol Endocrinol; 1993 Sep; 7(9):1169-77. PubMed ID: 8247019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proenkephalin gene expression: interaction of glucocorticoid and cAMP regulatory elements.
    Jenab S; Inturrisi CE
    Biochem Biophys Res Commun; 1995 May; 210(2):589-99. PubMed ID: 7755638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter.
    Morrison N; Eisman J
    J Bone Miner Res; 1993 Aug; 8(8):969-75. PubMed ID: 8213259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element.
    Harke N; Leers J; Kietz S; Drenckhahn D; Förster C
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):39-47. PubMed ID: 18782596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a cis-acting glucocorticoid responsive element in the rat angiotensin II type 1A promoter.
    Guo DF; Uno S; Ishihata A; Nakamura N; Inagami T
    Circ Res; 1995 Aug; 77(2):249-57. PubMed ID: 7614711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
    Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
    Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of A-raf expression.
    Lee JE; Beck TW; Wojnowski L; Rapp UR
    Oncogene; 1996 Apr; 12(8):1669-77. PubMed ID: 8622887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the mechanism of glucocorticoid-mediated repression from a negative glucocorticoid response element from the bovine prolactin gene.
    Subramaniam N; Cairns W; Okret S
    DNA Cell Biol; 1997 Feb; 16(2):153-63. PubMed ID: 9052736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative glucorticoid regulation of cyclic adenosine 3', 5'-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells.
    Guardiola-Diaz HM; Kolinske JS; Gates LH; Seasholtz AF
    Mol Endocrinol; 1996 Mar; 10(3):317-29. PubMed ID: 8833660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed secondary glucocorticoid response elements. Unusual nucleotide motifs specify glucocorticoid receptor binding to transcribed regions of alpha 2u-globulin DNA.
    Chan GC; Hess P; Meenakshi T; Carlstedt-Duke J; Gustafsson JA; Payvar F
    J Biol Chem; 1991 Nov; 266(33):22634-44. PubMed ID: 1718998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box.
    Meyer T; Gustafsson JA; Carlstedt-Duke J
    DNA Cell Biol; 1997 Aug; 16(8):919-27. PubMed ID: 9303434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SGK is a primary glucocorticoid-induced gene in the human.
    Náray-Fejes-Tóth A; Fejes-Tóth G; Volk KA; Stokes JB
    J Steroid Biochem Mol Biol; 2000 Dec; 75(1):51-6. PubMed ID: 11179908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter.
    Heinrichs AA; Bortell R; Rahman S; Stein JL; Alnemri ES; Litwack G; Lian JB; Stein GS
    Biochemistry; 1993 Oct; 32(42):11436-44. PubMed ID: 8218210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway.
    Park J; Leong ML; Buse P; Maiyar AC; Firestone GL; Hemmings BA
    EMBO J; 1999 Jun; 18(11):3024-33. PubMed ID: 10357815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a mineralocorticoid/glucocorticoid response element in the human Na/K ATPase alpha1 gene promoter.
    Kolla V; Robertson NM; Litwack G
    Biochem Biophys Res Commun; 1999 Dec; 266(1):5-14. PubMed ID: 10581156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the GDNF-inducible transcription factor (GIF) gene promoter by glucocorticoid and progesterone.
    Lee SH; Jang MK; Kim OS; Lee OH; Kim NY; Yoo KH; Lee DG; Shong YH; Mouradian MM
    J Steroid Biochem Mol Biol; 2009 May; 115(1-2):30-5. PubMed ID: 19429458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines.
    Russo FO; Patel PC; Ventura AM; Pereira CA
    Virus Res; 1999 Oct; 64(1):87-94. PubMed ID: 10500286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.